The purpose of this work is to increase the alertness of doctors treating cancer patients due to the high risk of developing acute coronary syndrome (ACS) and understanding the pathogenetic mechanisms of the development of ACS. Antitumor therapy should be personalized and agreed upon by an interdisciplinary team with an assessment of the impact on the risk of developing ACS, especially in patients with high cardiovascular risk. Given the limited number of studies, principles for the management of cancer patients with ACS should be based on an assessment of ischemic and hemorrhagic risks.
The article presents an intriguing clinical case of myocarditis in a 36-year-old patient following severe sunburn. The disease developed with a pronounced pain syndrome, a significant increase in high-sensitivity troponin levels, and notable changes in the electrocardiogram (ECG). These factors complicated the differential diagnosis between acute coronary syndrome (myocardial infarction without coronary obstruction) and myocarditis. The rapid regression of clinical symptoms, normalization of myocardial injury biomarkers, atypical ECG dynamics for myocardial infarction, and the absence of coronary artery changes during angiography—alongside magnetic resonance imaging data revealing no areas of ischemic changes but showing inflammatory changes and myocardial edema—contributed to a diagnosis of myocarditis. Dynamic observation two months post-diagnosis indicated no deviations from standard indicators. The article also reviews literature on the mechanisms of myocardial damage associated with sunburn, which differ significantly from those seen in thermal and chemical burns. The authors suggest that severe sunburn is the most likely etiological factor for the observed damage, highlighting the potential for injury not only to the skin but also to internal organs.
Introduction. The presence of diabetes mellitus in patients with acute infarction significantly worsens short- and long-term prognosis, but the features of the course of the infarction in this category of patients have not been fully studied.Objective. To compare clinical, functional and structural myocardial characteristics of patients with acute ST-segment elevation myocardial infarction with and without diabetes mellitus.Materials and methods. The study included 91 patients with revascularized ST-segment elevation myocardial infarction (41 patients with diabetes mellitus). All patients underwent cardiac MRI with contrast, including myocardial T1 mapping, tissue analysis of left ventricular myocardium with determination of infarct zone, heterogeneous zone, edema zone, pre- and post-contrast T1 values, extracellular volume values of healthy myocardium and infarct zone.Results. The presence of diabetes in patients with AMI was associated with increased EDV LV: 153 ± 38 and 181 ± 58 ml (p = 0.007), increased ESV LV: 76 ml [54–93] and 87 ml [71–122] (p = 0.035). Infarct size was significantly larger in patients with diabetes than in those without diabetes: 37 ± 15 g (95% CI: 33–41) and 47 ± 21 g (95% CI: 40–53), p = 0.017. Patients with acute infarction and diabetes mellitus had higher extracellular volume values in both healthy myocardium: 24% [22–27] and 28% [24–30], p = 0.002, and in the infarct zone: 48% [40–58] and 58% [50–61], p = 0.016.Conclusions. In patients with ST-segment elevation myocardial infarction with diabetes mellitus, the infarct size, the edema area, and the value of the extracellular volume fraction both in the infarct area and in the preserved myocardium were larger than in patients without diabetes, which may underlie the development of myocardial dysfunction and further progression of heart failure.